Back to VOLORIDGE INVESTMENT MANAGEMENT, LLC VOLORIDGE INVESTMENT MANAGEMENT, LLC

SYRESYRE
8 quarters

Position history for VOLORIDGE INVESTMENT MANAGEMENT, LLCVOLORIDGE INVESTMENT MANAGEMENT, LLC's holdings in Spyre Therapeutics, Inc

VOLORIDGE INVESTMENT MANAGEMENT, LLC previously held 0 shares of SYRE (Spyre Therapeutics, Inc), worth $0 as of 2025-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$7.1M

Total Shares Change

-188,053

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$31.88
0
2025-Q3
Decreased
264,317
-5.2%
$4.4M0.0%$16.36
0
2025-Q2
Increased
278,920
+8.3%
$4.2M0.0%$15.22
29
2025-Q1
Increased
257,432
+122.9%
$4.2M0.0%$17.94
43
2024-Q4
Decreased
115,470
-26.2%
$2.7M0.0%$22.54
0
2024-Q3
Decreased
156,481
-43.1%
$4.6M0.0%$28.49
0
2024-Q2
Increased
275,226
+46.4%
$6.5M0.0%$23.51
37
2024-Q1
New
188,053
-
$7.1M0.0%$37.93
38

Other major holders of SYRE: FMR LLC, BlackRock, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used